early Tuesday, Johnson & Johnson (J.N.J) reported adjusted earnings of $2.71 per share on revenue of $21.38 billion in the first quarter. Johnson & Johnson shares fell slightly.
X
Analysts polled by FactSet expected the pharmaceutical and medical giant to earn $2.64 per share and report revenue of $21.39 billion.
During the year-ago period, Johnson & Johnson earned $2.41 per share on revenue of $20.89 billion.
For the year, J&J expected adjusted earnings of $10.57 to $10.72 per share and revenue of $88 billion to $88.4 billion. Analysts expected earnings of $10.66 per share and $88.42 billion in revenue.
In premarket trading on today's stock market, shares of Johnson & Johnson fell 0.7% to 146.50.
More to follow.
Follow Allison Gatlin on X, the platform formerly known as Twitter, at @IBD_AGatlin.
YOU MAY ALSO LIKE:
Neumora Stock Hits Low in 2024 as Side Effects in Rabbits Torpedo Schizophrenia Drug
Why Wall Street got even more excited about the glucose monitor – and how Dexcom and Abbott Labs can benefit
Join IBD Live every morning before open for stock ideas
Want more IBD insights? Subscribe to our investing podcast!
Stocks to buy and watch: top IPOs, large and small caps, growth stocks
